While pharmacotherapy has strong support in treating mental illness, behavioral interventions have not been as thoroughly investigated. However, overwhelming evidence suggests that failure to integrate behavioral interventions limits patient quality of life. Individuals with PTSD, mood disorders, and addiction disorders are often worsened or precipitated by stressors. Muse is marketed as a brain sensing headband that can help train your brain to better respond to stress and improve your emotional state. A potential study would seek to determine whether Muse is an effective tool in improving patient outcomes for individuals with a mental illness that is affected by stress. Individuals who were recently diagnosed with a mental illness will be random assigned to a group that is getting standard pharmacotherapy alone or a group that is getting pharmacotherapy + the intervention (Muse). We would determine whether there is a significant difference in patient outcomes between the two groups.
How do we score?
Average Judge Score
10 judges have scored this entry. The highest possible score is 5 .1.5
We divide the average judge score with the maximum score possible and add 1 to create a multiplier.1.3
We apply the judge multiplier to the total number of crowd votes.2.6
- Invite Awaiting Confirmation Vote Voting has ended